DYN
Dyne Therapeutics, Inc. Common Stock ยท Health Care ยท NASDAQ
$20.87
โฒ $1.07 (+5.40%)
Market cap
$3.3B
52-week range
$8.06 โ $25.00
Volume
2.6M
Previous close
$19.80
Dyne Therapeutics, Inc. Common Stock (DYN) is held by 4 tracked hedge fund(s). Sector: Health Care. Largest tracked holder: Orbis Allan Gray Ltd.
| Fund | % of portfolio | Shares | Value | Latest activity | Avg buy price | Date |
|---|---|---|---|---|---|---|
| Orbis Allan Gray Ltd Orbis Allan Gray Ltd |
0.5% | 6.8M | $123M | โฒ 41% (+2.0M) | $19.56 | 2026-03-31 |
| ARMISTICE CAPITAL, LLC ARMISTICE CAPITAL, LLC |
1.0% | 3.2M | $58M | โผ 2.3% (โ75K) | $11.25 | 2026-03-31 |
| ORBIMED ADVISORS LLC ORBIMED ADVISORS LLC |
1.1% | 2.9M | $53M | โฒ 32% (+716K) | $28.39 | 2026-03-31 |
| Deep Track Capital, LP Deep Track Capital, LP |
0.6% | 2.0M | $36M | โผ 25% (โ650K) | $11.52 | 2026-03-31 |
FAQ โพ
Which hedge funds hold DYN?
Tracked holders include: Orbis Allan Gray Ltd, ARMISTICE CAPITAL, LLC, ORBIMED ADVISORS LLC, Deep Track Capital, LP.
How much smart money owns DYN?
4 tracked hedge fund(s) have disclosed positions.
Are members of Congress trading DYN?
No tracked Congressional trades in DYN on file.
Where does this data come from?
SEC 13F filings (funds), Form 4 (insiders) and STOCK Act reports (Congress).
Sourced from SEC 13F, Form 4 & STOCK Act filings ยท Not investment advice โพ
Ownership from SEC filings; price from market data.
Published by WealthFile ยท Not investment advice.